Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Zura Bio
ZURA
$383M
| $1.03M | ﹤0.01% |
174,395
+143,299
| +461% | +$682K |
2026 Q1
1 quarter
|
|
3002
Starz Entertainment Corp
STRZ
$425M
| $1.02M | ﹤0.01% |
35,443
+4,519
| +15% | +$98.4K |
2025 Q2
4 quarters
|
|
3003
Newsmax Inc
NMAX
$1.34B
| $1.02M | ﹤0.01% |
123,456
+11,935
| +11% | +$85.6K |
2025 Q2
4 quarters
|
|
3004
Northeast Community Bancorp
NECB
$380M
| $1M | ﹤0.01% |
36,144
+3,288
| +10% | +$81.7K |
2023 Q2
12 quarters
|
|
3005
DELISTED
Forte Biosciences
FBRX
| $1,000K | ﹤0.01% |
+47,043
| New | +$1.12M |
2026 Q2
0 quarters
|
|
3006
Genie Energy
GNE
$444M
| $998K | ﹤0.01% |
69,089
+13,087
| +23% | +$183K |
2019 Q2
28 quarters
|
|
3007
BayCom
BCML
$336M
| $998K | ﹤0.01% |
30,322
+3,022
| +11% | +$92.5K |
2022 Q2
16 quarters
|
|
3008
Blaize Holdings
BZAI
$39M
| $994K | ﹤0.01% |
720,616
+135,170
| +23% | +$238K |
2025 Q1
5 quarters
|
|
3009
Atomera
ATOM
$153M
| $987K | ﹤0.01% |
113,371
+27,171
| +32% | +$213K |
2020 Q2
24 quarters
|
|
3010
LENZ Therapeutics
LENZ
$113M
| $982K | ﹤0.01% |
172,807
+23,263
| +16% | +$188K |
2022 Q3
15 quarters
|
|
3011
Parke Bancorp
PKBK
$382M
| $981K | ﹤0.01% |
29,578
+3,250
| +12% | +$99.9K |
2022 Q2
16 quarters
|
|
3012
Timberland Bancorp
TSBK
$352M
| $980K | ﹤0.01% |
21,861
+2,161
| +11% | +$89.4K |
2023 Q2
12 quarters
|
|
3013
Tucows
TCX
$94.8M
| $979K | ﹤0.01% |
72,693
+2,033
| +3% | +$30.8K |
2017 Q2
36 quarters
|
|
3014
Nature's Sunshine
NATR
$224M
| $975K | ﹤0.01% |
44,720
-992
| -2% | -$23.1K |
2013 Q2
52 quarters
|
|
3015
Eledon Pharmaceuticals
ELDN
$198M
| $975K | ﹤0.01% |
247,404
+53,382
| +28% | +$194K |
2023 Q1
13 quarters
|
|
3016
MVB Financial
MVBF
$379M
| $972K | ﹤0.01% |
33,520
+4,336
| +15% | +$115K |
2018 Q2
32 quarters
|
|
3017
Costamare Bulkers Holdings
CMDB
$497M
| $966K | ﹤0.01% |
54,994
+73
| +0.1% | +$1.27K |
2025 Q2
4 quarters
|
|
3018
Radiant Logistics
RLGT
$425M
| $965K | ﹤0.01% |
101,978
+5,392
| +6% | +$45.4K |
2015 Q2
44 quarters
|
|
3019
Himalaya Shipping
HSHP
$847M
| $964K | ﹤0.01% |
72,141
+10,113
| +16% | +$146K |
2023 Q2
12 quarters
|
|
3020
QuickLogic
QUIK
$190M
| $954K | ﹤0.01% |
+47,756
| New | +$832K |
2026 Q2
0 quarters
|
|
3021
Benitec Biopharma
BNTC
$316M
| $948K | ﹤0.01% |
70,851
+9,440
| +15% | +$112K |
2025 Q2
4 quarters
|
|
3022
Kaltura
KLTR
$214M
| $944K | ﹤0.01% |
726,090
+49,771
| +7% | +$67.5K |
2021 Q3
19 quarters
|
|
3023
Comstock
LODE
$162M
| $943K | ﹤0.01% |
226,563
+170,314
| +303% | +$620K |
2025 Q4
2 quarters
|
|
3024
Silvaco Group
SVCO
$273M
| $942K | ﹤0.01% |
68,339
+6,192
| +10% | +$64.3K |
2024 Q2
8 quarters
|
|
3025
First Northern Community Bancorp
FNRN
$274M
| $939K | ﹤0.01% |
+52,368
| New | +$913K |
2026 Q2
0 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.